Definition: TP53 is a tumor suppressor gene that encodes the p53 protein, often called the “guardian of the genome.” It plays a crucial role in regulating cell cycle, DNA repair, and apoptosis.
Function
- DNA Damage Response: p53 is activated in response to DNA damage.
- Cell Cycle Arrest: It halts the cell cycle to allow DNA repair.
- Apoptosis: If damage is irreparable, p53 initiates programmed cell death to prevent propagation of mutations.
- Genomic Stability: Maintains the integrity of the genome by preventing mutation accumulation.
Clinical Significance in Oncology
- Mutations in TP53 are among the most common genetic alterations in human cancers (~50% of all tumors).
- Mutated p53 loses tumor suppressor function → uncontrolled cell proliferation and resistance to apoptosis.
- TP53 mutation is associated with:
- Poor prognosis in many cancers
- Resistance to chemotherapy and radiation therapy
- Higher tumor aggressiveness
Pharmacist Considerations
- Molecular testing for TP53 mutations may guide prognosis but currently has limited direct therapeutic targeting.
- Research ongoing on drugs that can restore or mimic p53 function.
- TP53 status may influence response to DNA-damaging agents and targeted therapies.
- Educate patients on the importance of genetic testing for personalized oncology care.
Key Takeaway:
TP53 is a critical tumor suppressor gene; mutations contribute to cancer development, treatment resistance, and prognosis, highlighting the importance of molecular profiling in oncology practice.